Benchmark analyst Bill Sutherland said the pullback in shares of Healthcare Services due to the company announcing that it would be late filing its 10-K appears overdone, noting that the company said that it does not expect the 10-K to reflect any changes to its results of operations as previously reported. The SEC inquiry into the company's approach to EPS calculation specifically focuses on its approach to rounding, added Sutherland, who expects the stock to recover once the inquiry is complete. He keeps a Buy rating and $50 price target on Healthcare Services shares.